Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Golovenko, M. Ya."'
Autor:
Golovenko, M. Ya.1 n.golovenko@gmail.com
Publikováno v:
Physiological Journal / Fiziologichnyi Zhurnal. 2022, Vol. 68 Issue 5, p89-103. 15p.
Autor:
Golovenko, M. Ya.1, Reder, A. S.2, Larionov, V. B.1, Andronati, S. A.1, Akisheva, A. S.3 n.golovenko@gmail.com
Publikováno v:
Biopolymers & Cell. 2021, Vol. 37 Issue 6, p459-468. 10p.
Autor:
Golovenko, M. Ya.1 n.golovenko@gmail.com, Larionov, V. B.1, Reder, A. S.1, Andronati, S. A.1, Valivodz’, I. P.1, Yurpalova, T. O.1
Publikováno v:
Neurophysiology. Feb2018, Vol. 50 Issue 1, p2-10. 9p.
Publikováno v:
Український біофармацевтичний журнал; № 1(54) (2018); 10-17
Ukraïns’kij bìofarmacevtičnij žurnal; № 1(54) (2018); 10-17
Украинский биофармацевтический журнал; № 1(54) (2018); 10-17
Ukraïns’kij bìofarmacevtičnij žurnal; № 1(54) (2018); 10-17
Украинский биофармацевтический журнал; № 1(54) (2018); 10-17
Introduction. One of 1.4-benzodiazepine 3-alcoxy derivatives – propoxazepam, possessing high analgetic action, also effectively suppressed different experimental seizures types. Unexpected combination of pharmacological spectrum components suggests
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::7114a07ace9f205a31adac63e4acb196
http://ubphj.nuph.edu.ua/article/view/ubphj.18.150
http://ubphj.nuph.edu.ua/article/view/ubphj.18.150
Autor:
Larionov, V. B.1 vitaliy.larionov@gmail.com, Golovenko, M. Ya.1
Publikováno v:
Physiological Journal / Fiziologichnyi Zhurnal. 2022 Supplement, Vol. 68, p22-22. 3/4p.
Publikováno v:
Клінічна фармація; Том 21, № 2 (2017); 34-40
Klìnìčna farmacìâ; Том 21, № 2 (2017); 34-40
Клиническая фармация; Том 21, № 2 (2017); 34-40
Clinical pharmacy; Vol. 21 No. 2 (2017); 34-40
Клиническая фармация; Том 21 № 2 (2017); 34-40
Клінічна фармація; Том 21 № 2 (2017); 34-40
Klìnìčna farmacìâ; Том 21, № 2 (2017); 34-40
Клиническая фармация; Том 21, № 2 (2017); 34-40
Clinical pharmacy; Vol. 21 No. 2 (2017); 34-40
Клиническая фармация; Том 21 № 2 (2017); 34-40
Клінічна фармація; Том 21 № 2 (2017); 34-40
Aim. To study the mechanisms of action for propoxazepam, a new compound with the analgesic action, on the model of thiosemicarbazide-induced GABA-deficient seizures.Matherials and methods. A chemoconvulsive agent was injected subcutaneously (20 mg/kg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4abd7e0cde8431cd7e77174c101db5ed
http://cphj.nuph.edu.ua/article/view/cphj.17.1419
http://cphj.nuph.edu.ua/article/view/cphj.17.1419
Publikováno v:
Clinical pharmacy; Vol. 20 No. 3 (2016); 24-28
Клиническая фармация; Том 20 № 3 (2016); 24-28
Клінічна фармація; Том 20 № 3 (2016); 24-28
Клиническая фармация; Том 20 № 3 (2016); 24-28
Клінічна фармація; Том 20 № 3 (2016); 24-28
Development of pathogenetic therapy of acute ethanol poisoning is of undoubted interest since such intoxication is often accompanied by a severe course and high lethality. Taking into account the peculiarities of the ethanol pathological action the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=issn1562725X::10c510308bcc5c540ca66e65a1129a3f
http://cphj.nuph.edu.ua/article/view/cphj.16.1382
http://cphj.nuph.edu.ua/article/view/cphj.16.1382
Autor:
Golovenko, M. Ya., Larionov, V. B.
Publikováno v:
Ukrainian Biochemical Journal; Jul/Aug2014, Vol. 86 Issue 4, p150-157, 8p
Publikováno v:
EUREKA: Health Sciences. 2022, Issue 5, p10-18. 9p.
Publikováno v:
Ukrainica Bioorganica Acta. 2011, Vol. 9 Issue 2, p28-31. 4p. 2 Diagrams.